Home › Childbirth Problems › NCT04303702
The Role of Oxytocin in the Second Stage of Labor
RecruitingHealthy volunteers welcome
Role of Oxytocin in the Second Stage of Labor: a Randomized Controlled Trial (The ROSSoL Trial)
Who can join
All ages · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Nulliparous pregnant women \>/= 37 weeks gestation * Singleton pregnancies * Admission for induction of labor or spontaneous labor Exclusion Criteria: * Multiple gestations * Multiparous patients * Patients with major fetal anomalies * Not on oxytocin at the time of complete cervical dilation * Patients with fetal head visible at the perineum on diagnosis of complete cervical dilation * Maternal medical condition that prohibits prolonged second stage
About the study
This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.
What is being tested
- Continue Oxytocin (drug)
- Discontinue Oxytocin (other)
Sponsor: Washington University School of Medicine · Participants: 400 · Started: Jul 1, 2022
Contact the study team
- Nandini Raghuraman, MD MSCI · Phone: 9186917389
Official record on ClinicalTrials.gov — NCT04303702
Locations in the U.S.
| Missouri | Barnes Jewish Hospital, St Louis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.